Edward Nash
Recent Articles about Verona Pharma Plc
Pharma Co. Secures $650M Strategic Financing 05/16/2024
According to a Canaccord Genuity research note, Verona Pharma Plc. received a US$650 million strategic financing, which management believes will extend the cash runway beyond 2026 and fund the upcoming commercial activities related to the potential FDA approval of ensifentrine.
PDUFA Date Coming Up for U.K. Biopharma 04/22/2024
The company has a commercialization plan in place and is preparing further for approval, noted a Canaccord Genuity report.
© 2024 Streetwise Reports. All rights reserved.
Streetwise Reports is registered with the U.S. Patent and Trademark Office.
